Search - tctmd.com

Displaying 661 - 680 of 1104

Sort: Relevancy | Date

News Daily News

Noninvasive Test Links Pre-Angiography Fluid Volume to Later Kidney Damage

Caitlin E. Cox

February 12, 2014

News Daily News

A-fib Common After Aortic Valve Replacement

Jason Kahn

January 30, 2014

Presentation Cell Therapy 2014

Prevention of Remodeling and CHF after Acute MI: PRESERVATION-I

Presenter: Reinilde Heyrman

January 22, 2014

News Daily News

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Yael L. Maxwell

January 01, 2014

News Daily News

Watchman Logra un Apoyo Importante del Panel de Asesores de la FDA

Yael L. Maxwell

January 01, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

January 01, 2014

News Daily News

Adjunctive Cilostazol Improves Ischemic Outcomes in Carotid Artery Stenting Patients

January 01, 2014

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY：达比加群在不同肾功能患者中安全、有效

Yael L. Maxwell

December 30, 2013

News Industry News

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

December 16, 2013

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Daily News

阿哌沙班在治疗接受心脏复律的房颤患者方面不劣于华法林

December 05, 2013

News Daily News

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

December 05, 2013

News Daily News

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

December 05, 2013

News Daily News

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

December 05, 2013

Presentation

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Presenter: William A. Gray

December 02, 2013

Presentation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Presenter: Roxana Mehran

December 01, 2013

Presentation

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Presenter: Martin T. Rothman

December 01, 2013

Advertisement

Noninvasive Test Links Pre-Angiography Fluid Volume to Later Kidney Damage

A-fib Common After Aortic Valve Replacement

Prevention of Remodeling and CHF after Acute MI: PRESERVATION-I

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Watchman Logra un Apoyo Importante del Panel de Asesores de la FDA

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

Adjunctive Cilostazol Improves Ischemic Outcomes in Carotid Artery Stenting Patients

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

RE-LY：达比加群在不同肾功能患者中安全、有效

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

阿哌沙班在治疗接受心脏复律的房颤患者方面不劣于华法林

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content